市場調査レポート

商品コード

1630636

男性乳がん治療市場規模、シェア、成長分析、タイプ別、製品タイプ別、治療別、診断別、エンドユーザー別、地域別 - 産業予測、2025-2032年

Male Breast Cancer Treatment Market Size, Share, Growth Analysis, By Type, By Product Type, By Treatment, By Diagnosis, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年01月07日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

男性乳がん治療の世界市場規模は、2023年に44億米ドルと評価され、予測期間（2025-2032年）のCAGRは3.7%で、2024年の45億6,000万米ドルから2032年には61億米ドルに成長する見通しです。

男性乳がんはまれではあるが、特に人口の高齢化と肥満率の上昇に伴い、重大な懸念事項として浮上しています。このタイプのがんは、乳房組織の急速な細胞分裂から発生し、多くの場合BRCA2などの遺伝子変異と関連しており、主に高齢の男性が罹患し、生涯で833人に1人が罹患するリスクがあります。興味深いことに、がん全体の1％にも満たないです。しかし、認知度の向上により、早期診断と効果的な治療オプションによって生存率は改善しています。主な市場促進要因としては、 Bristol-Myers Squibb と Clovis Oncology の連携などによって証明されているように、がん患者の増加やバイオテクノロジーの進歩が挙げられます。しかし、調査費用の高さや、一貫した治療戦略の欠如といった課題も残っており、これが市場成長の妨げになる可能性があります。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Pfizer Inc.（USA）
Johnson & Johnson（USA）
Novartis AG（Switzerland）
Roche Holding AG（Switzerland）
GlaxoSmithKline plc（UK）
Sanofi S.A.（France）
Bayer AG（Germany）
Bristol-Myers Squibb Company（USA）
Eli Lilly and Company（USA）
AstraZeneca plc（UK）
Teva Pharmaceutical Industries Ltd.（Israel）
Sun Pharmaceutical Industries Ltd.（India）
BioNumerik Pharmaceuticals, Inc.（USA）
Seattle Genetics, Inc.（USA）
Accord Healthcare Ltd.（UK）
Merck & Co., Inc.（USA）
Fresenius SE & Co. KGaA（Germany）
Mylan N.V.（USA）
AbbVie Inc.（USA）
Amgen Inc.（USA）

結論と推奨事項

Product Code: SQMIG35D2234

Global Male Breast Cancer Treatment Market size was valued at USD 4.4 billion in 2023 and is poised to grow from USD 4.56 billion in 2024 to USD 6.1 billion by 2032, growing at a CAGR of 3.7% during the forecast period (2025-2032).

Male breast cancer, although rare, is emerging as a significant concern, particularly as the population ages and obesity rates rise. This cancer type arises from rapid cell division in breast tissue, often linked to genetic mutations such as BRCA2, predominantly affecting older men, with 1 in 833 at risk over their lifetime. Interestingly, it accounts for less than 1% of all cancers. However, increased awareness has improved survival rates through early diagnosis and effective treatment options. Key market drivers include a rise in cancer cases and advancements in biotechnology, as evidenced by collaborations like that of Bristol-Myers Squibb and Clovis Oncology. However, challenges remain, such as the high cost of research and the lack of a cohesive treatment strategy, which may hinder market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Male Breast Cancer Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Male Breast Cancer Treatment Market Segmental Analysis

Global Male Breast Cancer Treatment Market is segmented by Type, Product Type, Treatment, Diagnosis, End User and region. Based on Type, the market is segmented into Ductal Carcinoma in Situ, Paget's Disease of the Nipple, Inflammatory Breast Cancer, Infiltrating Ductal carcinoma and Others. Based on Product Type, the market is segmented into Chemotherapy, Medication and Others. Based on Treatment, the market is segmented into Local Treatments, Radiation Therapy, Targeted Therapy and Systemic Treatments. Based on Diagnosis, the market is segmented into Mammography, Biopsy, Fine Needle Aspiration Biopsy, Core Biopsy, Excisional Biopsy, PET Scan, CT Scan, MRI Scan and Other Tests. Based on End User, the market is segmented into Hospitals, Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Male Breast Cancer Treatment Market

The global market for male breast cancer treatment is significantly driven by rising awareness and enhanced early detection efforts. Initiatives and campaigns aimed at educating the public have played a crucial role in promoting the importance of recognizing the signs of male breast cancer, leading to timely diagnoses. Early detection is fundamental to improving survival rates and treatment success, as it enables healthcare providers to initiate appropriate therapies sooner. Furthermore, advancements in diagnostic technologies and the implementation of comprehensive screening programs have contributed to better patient outcomes, underscoring the critical importance of awareness in combating this rare condition.

Restraints in the Global Male Breast Cancer Treatment Market

The Global Male Breast Cancer Treatment market faces significant restraints due to the limited number of clinical trials and research focused specifically on male patients. This is largely because male breast cancer is rarer than female breast cancer, resulting in insufficient gender-specific research to inform treatment protocols. Consequently, treatment options may be based primarily on data derived from studies primarily involving women, which may not effectively address the unique needs of male patients. This scarcity of targeted research creates challenges in formulating optimal care plans and can potentially compromise the effectiveness of treatments intended for men diagnosed with breast cancer.

Market Trends of the Global Male Breast Cancer Treatment Market

The Global Male Breast Cancer Treatment market is experiencing a significant transformation driven by rising awareness and the evolving oncology landscape. Historically overshadowed by female breast cancer, the increasing recognition of male breast cancer has prompted dedicated research and development initiatives. Notably, a surge in male breast cancer cases has catalyzed the medical community to allocate resources towards specialized treatments and innovative therapies. This paradigm shift is fostering collaboration among researchers, clinicians, and advocates, culminating in enhanced early detection, personalized treatment options, and improved outcomes for affected men. The market is poised for growth as it increasingly focuses on addressing this unique patient demographic.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Male Breast Cancer Treatment Market Size by Type & CAGR (2025-2032)

Market Overview
Ductal Carcinoma in Situ
Paget's Disease of the Nipple
Inflammatory Breast Cancer
Infiltrating Ductal carcinoma
Others

Global Male Breast Cancer Treatment Market Size by Product Type & CAGR (2025-2032)

Market Overview
Chemotherapy
Medication
Others

Global Male Breast Cancer Treatment Market Size by Treatment & CAGR (2025-2032)

Market Overview
Local Treatments
Radiation Therapy
Targeted Therapy
Systemic Treatments

Global Male Breast Cancer Treatment Market Size by Diagnosis & CAGR (2025-2032)

Market Overview
Mammography
Biopsy
Fine Needle Aspiration Biopsy
Core Biopsy
Excisional Biopsy
PET Scan
CT Scan
MRI Scan
Other Tests

Global Male Breast Cancer Treatment Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Others

Global Male Breast Cancer Treatment Market Size & CAGR (2025-2032)

North America (Type, Product Type, Treatment, Diagnosis, End User)
- US
- Canada
Europe (Type, Product Type, Treatment, Diagnosis, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Product Type, Treatment, Diagnosis, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Product Type, Treatment, Diagnosis, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Product Type, Treatment, Diagnosis, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioNumerik Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seattle Genetics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accord Healthcare Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

男性乳がん治療市場規模、シェア、成長分析、タイプ別、製品タイプ別、治療別、診断別、エンドユーザー別、地域別 - 産業予測、2025-2032年

Male Breast Cancer Treatment Market Size, Share, Growth Analysis, By Type, By Product Type, By Treatment, By Diagnosis, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

男性乳がん治療市場規模：タイプ別

男性乳がん治療市場規模：製品タイプ別

男性乳がん治療市場規模：治療別

男性乳がん治療市場規模：診断別

男性乳がん治療市場規模：エンドユーザー別

男性乳がん治療市場規模